Shoreline Biosciences
Blood & Organ Banks · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
11408 Sorrento Valley Rd, San Diego, Cal...Phone Number
(858) 997-2703Website
www.shorelinebio.comRevenue
<$5 MillionIndustry
ZI Rank: 4
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
4
2
7
7
2
4
About Shoreline Biosciences
Founded in 2020 and headquartered in San Diego, United States, Shoreline is a biotechnology company creating next-generation cellular immunotherapies for cancer that overcome the current limitations of first-generation cell therapy products.Explore more
Shoreline Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Shoreline Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Shoreline Biosciences has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Shoreline Biosciences
Product Launch: Get notified when Shoreline Biosciences launches new products
Funding: Get notified immidiatlly once Shoreline Biosciences has new funding data
Check out if Shoreline Biosciences is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Shoreline Biosciences had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Shoreline Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Shoreline Biosciences recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Shoreline Biosciences as Masked Content
Find more new buyers
Compare Similar Companies to Shoreline Biosciences
Compare insights from companies similar to Shoreline Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Shoreline Biosciences is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Shoreline Biosciences is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Shoreline Biosciences.
Shoreline Biosciences financials insights
Gather financial insights about Shoreline Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Other Financing Round
$43M
Unspecified
$140M
Shoreline Biosciences Tech Stack
A closer look at the technologies used by Shoreline Biosciences
See more technologies
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Left Company
Executive Move
Executive Moves, Left Company
Layoffs
Research & Development, Layoffs, Medical Research
Open Position
Executive Move
Executive Moves, Board of Directors
Shoreline Biosciences News & Media
SHORELINE BIOSCIENCES WINS A COMPREHENSIVE SUMMARY JUDGEMENT VICTORY ON ALL CLAIMS BROUGHT BY FATE THERAPEUTICS AND WHITEHEAD INSTITUTE ON IPSC GENERATION AND USE
SAN DIEGO, Sept. 7, 2023 /PRNewswire/ -- Shoreline Biosciences, Inc., a biopharmaceutical company developing effective and differentiated cellular immunotherapies based on induced pluripotent stem cells (iPSCs) derived natural killer cells (iNKs) and macrophages (iMACs), today announced a...SHORELINE BIOSCIENCES TO PARTICIPATE AT THE 2023 WEDBUSH PACGROW HEALTHCARE CONFERENCE
SAN DIEGO, Aug. 3, 2023 /PRNewswire/ -- Shoreline Biosciences, Inc. (Shoreline), a biopharmaceutical company developing effective and differentiated cellular immunotherapies based on induced pluripotent stem cells (iPSCs) derived natural killer cells (iNK) and macrophages (iMACs), today...Shoreline Biosciences Presents Data at AACR 2023 Demonstrating Novel Methodology to Produce Clinical Scale iPSC-derived NK (iNK) Cells
SAN DIEGO, March 16, 2023 /PRNewswire/ -- Shoreline Biosciences, Inc. (Shoreline), a biopharmaceutical company developing next-generation cellular immunotherapies based on induced pluripotent stem cells (iPSCs) utilizing its proprietary iPSC-derived natural killer (iNK) cell and...Shoreline Biosciences Announces Appointment of Mauro P. Avanzi, M.D., Ph.D., As Chief Medical Officer
SAN DIEGO, Feb. 21, 2023 /PRNewswire/ -- Shoreline Biosciences, Inc. (Shoreline), a biopharmaceutical company developing next-generation cellular immunotherapies based on induced pluripotent stem cells (iPSCs) utilizing its proprietary iPSC-derived natural killer (iNK) cell and macrophage...
Read more news
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Shoreline Biosciences
Sign Up For FreeTo access detailed company insights
Founded in 2020 and headquartered in San Diego, United States, Shoreline is a biotechnology company creating next-generation cellular immunotherapies for cancer that overcome the current limitations of first-generation cell therapy products.... Read More
